Harrow Health (NASDAQ: HROW)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-09 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | 0.030 | 0.0600 | ||||
REV | 19.480M | 22.120M | 2.640M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Harrow Health (NASDAQ: HROW) through any online brokerage.
Other companies in Harrow Health’s space includes: Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), CymaBay Therapeutics (NASDAQ:CBAY), Provention Bio (NASDAQ:PRVB) and Rani Therapeutics Hldgs (NASDAQ:RANI).
The latest price target for Harrow Health (NASDAQ: HROW) was reported by B. Riley Securities on Friday, May 20, 2022. The analyst firm set a price target for 20.00 expecting HROW to rise to within 12 months (a possible 174.73% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Harrow Health (NASDAQ: HROW) is $7.28 last updated June 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Harrow Health.
Harrow Health’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Harrow Health.
Harrow Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.